Recorded webinar: Clinical Evaluation of an FDA-Cleared High-Throughput Rapid Antibiotic Susceptibility Testing System
Recorded webinar: Clinical Evaluation of an FDA-Cleared High-Throughput Rapid Antibiotic Susceptibility Testing System
With increasing antimicrobial resistance, providing rapid antibiotic susceptibility testing (AST) results to clinicians treating bacteremia patients is becoming ever more important. Hopefully, such fast, potentially life-saving answers will soon become the standard of care for these seriously ill patients.
In this recorded webinar, speakers from two US clinical microbiology labs discussed their evaluation of ASTar System. They described their motivation for exploring rapid AST options for positive blood cultures, their labs’ experience with ASTar’s usability, and the timing and accuracy of its results compared to legacy AST methods. They also discussed retrospective chart reviews of patients to examine the potential clinical impact of faster AST results for patients with bacteremia and sepsis.
The webinar was originally broadcasted on September 18, 2024.
Speakers:
Elizabeth Garrett, PhD, D(ABMM)
Associate Director of Microbiology, Penn State Hershey Medical Center
With increasing antimicrobial resistance, providing rapid antibiotic susceptibility testing (AST) results to clinicians treating bacteremia patients is becoming ever more important. Hopefully, such fast, potentially life-saving answers will soon become the standard of care for these seriously ill patients.
In this recorded webinar, speakers from two US clinical microbiology labs discussed their evaluation of ASTar System. They described their motivation for exploring rapid AST options for positive blood cultures, their labs’ experience with ASTar’s usability, and the timing and accuracy of its results compared to legacy AST methods. They also discussed retrospective chart reviews of patients to examine the potential clinical impact of faster AST results for patients with bacteremia and sepsis.
The webinar was originally broadcasted on September 18, 2024.
